U.S. FDA Approves First Experimental Zika Vaccine for Clinical Trials
June 22, 2016| |
The U.S. Food and Drug Administration (US FDA) approved the clinical trial of an experimental vaccine for Zika virus for the first time. The first experimental vaccine for Zika was developed by Inovio. The initial results of the trial, which will involve 40 adults, are expected to come out later this year.
The vaccine developed by Inovio with a working name of GLS-5700 is a DNA vaccine. When injected, it involves coding of DNA to produce the protein that surrounds the Zika virus. Electrical pulse is applied to the site of injection to help the DNA locate the cells. Then the cells teach the immune system to detect Zika virus as a foreign invader, producing antibodies to combat the virus.
Read the original article from Stat News.
| |
Biotech Updates is a weekly newsletter of ISAAA, a not-for-profit organization. It is distributed for free to over 22,000 subscribers worldwide to inform them about the key developments in biosciences, especially in biotechnology. Your support will help us in our mission to feed the world with knowledge. You can help by donating as little as $10.
-
See more articles:
-
News from Around the World
- New Report Says Bioenergy Can Support Food Security
- Ghanaian Scientists Urge Gov't to Invest in Agricultural Research
- Tanzania is Ready for GM Crops, Affirms Permanent Secretary of Ministry of Agri
- USSEC and USGC Collaborate to Highlight Science-based Regulatory System in EU
- ISAAA Launched 2015 Biotech Crops Report in Myanmar
- Scientists Find Animal Hormone Melatonin is Involved in Plant Stress Tolerance
- University of Leeds Study Reports Crop Breeding Not Keeping Pace with Climate Change
-
Research Highlights
- Tissue-specific Expression of AtNPR1 Gene in Rice Confers Sheath Blight Resistance
- Identification and Characterization of Nicotianamine Synthase Genes in Bread Wheat
- Bt Eggplant Performance in the Philippines for the Control of the Eggplant Fruit and Shoot Borer
-
Beyond Crop Biotech
- U.S. FDA Approves First Experimental Zika Vaccine for Clinical Trials
- Rice University Researchers Synthesizes New Cancer Fighter
- E-cigarette Use Alter Genes Involved in Airway Immune Defense
-
Announcements
- Program Management for Plant Breeders Course
-
Resources
- Forest and Farm Producer Organizations-Operating Systems for the SDGs
-
Read the latest: - Biotech Updates (October 9, 2024)
- Gene Editing Supplement (September 26, 2024)
- Gene Drive Supplement (February 22, 2023)
-
Subscribe to BU: - Share
- Tweet